T80.810SICD-10-CM 2027 · Abrechenbar
Extravasation of vesicant antineoplastic chemotherapy, sequela
Geschwistercodes
Vererbt von T80.810: Extravasation of vesicant antineoplastic chemotherapy
Inclusion terms
- Infiltration of vesicant antineoplastic chemotherapy
Vererbt von T80.81: Extravasation of vesicant agent
Inclusion terms
- Infiltration of vesicant agent
Vererbt von T80: Complications following infusion, transfusion and therapeutic injection
7th character
- A = initial encounter
- D = subsequent encounter
- S = sequela
7th character note
- The appropriate 7th character is to be added to each code from category
T80
Excludes2
- bone marrow transplant rejection (
T86.01) - febrile nonhemolytic transfusion reaction (
R50.84) - fluid overload due to transfusion (
E87.71) - posttransfusion purpura (
D69.51) - transfusion associated circulatory overload (TACO) (
E87.71) - transfusion (red blood cell) associated hemochromatosis (
E83.111) - transfusion related acute lung injury (TRALI) (
J95.84)
Includes
- complications following perfusion
Teil von: T80.810: Extravasation of vesicant antineoplastic chemotherapy › T80.81: Extravasation of vesicant agent › T80.8: Other complications following infusion, transfusion and therapeutic injection › T80: Complications following infusion, transfusion and therapeutic injection